C4 Therapeutics bumps Andrew Phillips to CEO; Milind DeshÂpande exits Achillion; Leena Gandhi to head up I/O at Eli Lilly
→ Andrew Phillips has been diving deep into the biotech side of things ever since he left the academia to join …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
